新世界发展(00017.HK)初创企业加速计划Impact Kommons挑选15初创 六成为本地企业
新世界发展(00017.HK)公布,旗下全亚洲首个以联合国可持续发展目标(UNSDG)为蓝本的初创企业加速计划Impact Kommons展开新一阶段,挑选15间初创企业,以集团的网络及资源协助入选其业务及方案商品化,并协助集团业务应用创新解决方案。
第二轮计划有来自30个不同国家及地区的初创企业申请,最终15间凭藉其方案的独特性脱颖而出,有达六成为本地企业,反映他们在可持续发展方案方面的潜力及商机。当中有入选初创的产品有效加强防疫抗疫的措施,并已获集团旗下的物业采用。(el/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.